|
1
|
Verbeke C, Löhr M, Karlsson JS and Del
Chiaro M: Pathology reporting of pancreatic cancer following
neoadjuvant therapy: Challenges and uncertainties. Cancer Treat
Rev. 41:17–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verbeke C: Morphological heterogeneity in
ductal adenocarcinoma of the pancreas-Does it matter?
Pancreatology. 16:295–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fan Y, Xu LL, Shi CY, Wei W, Wang DS and
Cai DF: MicroRNA-454 regulates stromal cell derived factor-1 in the
control of the growth of pancreatic ductal adenocarcinoma. Sci Rep.
6:227932016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miao F, Zhu J, Chen Y, Tang N, Wang X and
Li X: MicroRNA-183-5p promotes the proliferation, invasion and
metastasis of human pancreatic adenocarcinoma cells. Oncol Lett.
11:134–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Wu G, Wu Z, Yao X and Li G: MiR-200a
suppresses the proliferation and metastasis in pancreatic ductal
adenocarcinoma through downregulation of DEK gene. Transl Oncol.
9:25–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu C, Wang M, Li Z, Xiao J, Peng F, Guo X,
Deng Y, Jiang J and Sun C: MicroRNA-138-5p regulates pancreatic
cancer cell growth through targeting FOXC1. Cell Oncol (Dordr).
38:173–181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vetter G, Saumet A, Moes M, Vallar L, Le
Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH and
Friederich E: miR-661 expression in SNAI1-induced epithelial to
mesenchymal transition contributes to breast cancer cell invasion
by targeting Nectin-1 and StarD10 messengers. Oncogene.
29:4436–4448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu T, Yuan J, Wang Y, Gong C, Xie Y and
Li H: MiR-661 contributed to cell proliferation of human ovarian
cancer cells by repressing INPP5J expression. Biomed Pharmacother.
75:123–128. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu F, Cai Y, Rong X, Chen J, Zheng D,
Chen L, Zhang J, Luo R, Zhao P and Ruan J: MiR-661 promotes tumor
invasion and metastasis by directly inhibiting RB1 in non small
cell lung cancer. Mol Cancer. 16:1222017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arensman MD, Kovochich AN, Kulikauskas RM,
Lay AR, Yang PT, Li X, Donahue T, Major MB, Moon RT, Chien AJ and
Dawson DW: WNT7B mediates autocrine Wnt/β-catenin signaling and
anchorage-independent growth in pancreatic adenocarcinoma.
Oncogene. 33:899–908. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wald P, Liu XS, Pettit C, Dillhoff M,
Manilchuk A, Schmidt C, Wuthrick E, Chen W and Williams TM:
Prognostic value of microRNA expression levels in pancreatic
adenocarcinoma: A review of the literature. Oncotarget.
8:73345–73361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song B, Ji W, Guo S, Liu A, Jing W, Shao
C, Li G and Jin G: miR-545 inhibited pancreatic ductal
adenocarcinoma growth by targeting RIG-I. FEBS Lett. 588:4375–4381.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang R, Leng H, Huang J, Du Y, Wang Y,
Zang W, Chen X and Zhao G: miR-337 regulates the proliferation and
invasion in pancreatic ductal adenocarcinoma by targeting HOXB7.
Diagn Pathol. 9:1712014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song B, Zheng K, Ma H, Liu A, Jing W, Shao
C, Li G and Jin G: miR-429 determines poor outcome and inhibits
pancreatic ductal adenocarcinoma growth by targeting TBK1. Cell
Physiol Biochem. 35:1846–1856. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sano M, Driscoll DR, DeJesus-Monge WE,
Quattrochi B, Appleman VA, Ou J, Zhu LJ, Yoshida N, Yamazaki S,
Takayama T, et al: Activation of WNT/β-catenin signaling enhances
pancreatic cancer development and the malignant potential via
Up-regulation of Cyr61. Neoplasia. 18:785–794. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang Y, Li Z, Zheng S, Chen H, Zhao X,
Gao W, Bi Z, You K, Wang Y, Li W, et al: The long non-coding RNA
HOTAIR affects the radiosensitivity of pancreatic ductal
adenocarcinoma by regulating the expression of Wnt inhibitory
factor 1. Tumour Biol. 37:3957–3967. 2016. View Article : Google Scholar : PubMed/NCBI
|
